Guidelines for neuroleptic relapse prevention in schizophrenia proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Berlin u.a.
Springer
1991
|
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV004446837 | ||
| 003 | DE-604 | ||
| 005 | 20180125 | ||
| 007 | t| | ||
| 008 | 910603s1991 gw |||| 10||| eng d | ||
| 020 | |a 3540539859 |9 3-540-53985-9 | ||
| 020 | |a 0387539859 |9 0-387-53985-9 | ||
| 035 | |a (OCoLC)23650780 | ||
| 035 | |a (DE-599)BVBBV004446837 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c DE | ||
| 049 | |a DE-12 |a DE-29 |a DE-188 |a DE-578 | ||
| 050 | 0 | |a RC514 | |
| 082 | 0 | |a 616.89/82061 |2 20 | |
| 084 | |a YH 6105 |0 (DE-625)153561:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Guidelines for neuroleptic relapse prevention in schizophrenia |b proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium |c ed. by Werner Kissling |
| 264 | 1 | |a Berlin u.a. |b Springer |c 1991 | |
| 300 | |a VIII, 166 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Antipsychotic Agents |x therapeutic use |v Congresses | |
| 650 | 4 | |a Antipsychotic Agents |x therapeutic use |v Practice Guideline | |
| 650 | 4 | |a Antipsychotic drugs |v Congresses | |
| 650 | 4 | |a Schizophrenia |x Chemotherapy |v Congresses | |
| 650 | 4 | |a Schizophrenia |x Relapse |x Prevention |v Congresses | |
| 650 | 4 | |a Schizophrenia |x drug therapy |v Congresses | |
| 650 | 4 | |a Schizophrenia |x drug therapy |v Practice Guideline | |
| 650 | 4 | |a Schizophrenia |x prevention & control |v Congresses | |
| 650 | 4 | |a Schizophrenia |x prevention & control |v Practice Guideline | |
| 650 | 0 | 7 | |a Rezidivprophylaxe |0 (DE-588)4177967-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Schizophrenie |0 (DE-588)4052527-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Neuroleptikum |0 (DE-588)4041885-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Internationaler Vergleich |0 (DE-588)4120509-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1989 |z Brügge |2 gnd-content | |
| 689 | 0 | 0 | |a Schizophrenie |0 (DE-588)4052527-2 |D s |
| 689 | 0 | 1 | |a Neuroleptikum |0 (DE-588)4041885-6 |D s |
| 689 | 0 | 2 | |a Rezidivprophylaxe |0 (DE-588)4177967-8 |D s |
| 689 | 0 | 3 | |a Internationaler Vergleich |0 (DE-588)4120509-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Kissling, Werner |e Sonstige |0 (DE-588)17218746X |4 oth | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-002758892 | |
Datensatz im Suchindex
| _version_ | 1819229501625729024 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)17218746X |
| building | Verbundindex |
| bvnumber | BV004446837 |
| callnumber-first | R - Medicine |
| callnumber-label | RC514 |
| callnumber-raw | RC514 |
| callnumber-search | RC514 |
| callnumber-sort | RC 3514 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | YH 6105 |
| ctrlnum | (OCoLC)23650780 (DE-599)BVBBV004446837 |
| dewey-full | 616.89/82061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.89/82061 |
| dewey-search | 616.89/82061 |
| dewey-sort | 3616.89 582061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02185nam a2200541 c 4500</leader><controlfield tag="001">BV004446837</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180125 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">910603s1991 gw |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3540539859</subfield><subfield code="9">3-540-53985-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0387539859</subfield><subfield code="9">0-387-53985-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)23650780</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004446837</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC514</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.89/82061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YH 6105</subfield><subfield code="0">(DE-625)153561:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Guidelines for neuroleptic relapse prevention in schizophrenia</subfield><subfield code="b">proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium</subfield><subfield code="c">ed. by Werner Kissling</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin u.a.</subfield><subfield code="b">Springer</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 166 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Practice Guideline</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic drugs</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="x">Relapse</subfield><subfield code="x">Prevention</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Practice Guideline</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="x">prevention & control</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="x">prevention & control</subfield><subfield code="v">Practice Guideline</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rezidivprophylaxe</subfield><subfield code="0">(DE-588)4177967-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Schizophrenie</subfield><subfield code="0">(DE-588)4052527-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neuroleptikum</subfield><subfield code="0">(DE-588)4041885-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Internationaler Vergleich</subfield><subfield code="0">(DE-588)4120509-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1989</subfield><subfield code="z">Brügge</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Schizophrenie</subfield><subfield code="0">(DE-588)4052527-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Neuroleptikum</subfield><subfield code="0">(DE-588)4041885-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Rezidivprophylaxe</subfield><subfield code="0">(DE-588)4177967-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Internationaler Vergleich</subfield><subfield code="0">(DE-588)4120509-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kissling, Werner</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)17218746X</subfield><subfield code="4">oth</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002758892</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1989 Brügge gnd-content |
| genre_facet | Konferenzschrift 1989 Brügge |
| id | DE-604.BV004446837 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-23T11:14:11Z |
| institution | BVB |
| isbn | 3540539859 0387539859 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002758892 |
| oclc_num | 23650780 |
| open_access_boolean | |
| owner | DE-12 DE-29 DE-188 DE-578 |
| owner_facet | DE-12 DE-29 DE-188 DE-578 |
| physical | VIII, 166 S. |
| publishDate | 1991 |
| publishDateSearch | 1991 |
| publishDateSort | 1991 |
| publisher | Springer |
| record_format | marc |
| spelling | Guidelines for neuroleptic relapse prevention in schizophrenia proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium ed. by Werner Kissling Berlin u.a. Springer 1991 VIII, 166 S. txt rdacontent n rdamedia nc rdacarrier Antipsychotic Agents therapeutic use Congresses Antipsychotic Agents therapeutic use Practice Guideline Antipsychotic drugs Congresses Schizophrenia Chemotherapy Congresses Schizophrenia Relapse Prevention Congresses Schizophrenia drug therapy Congresses Schizophrenia drug therapy Practice Guideline Schizophrenia prevention & control Congresses Schizophrenia prevention & control Practice Guideline Rezidivprophylaxe (DE-588)4177967-8 gnd rswk-swf Schizophrenie (DE-588)4052527-2 gnd rswk-swf Neuroleptikum (DE-588)4041885-6 gnd rswk-swf Internationaler Vergleich (DE-588)4120509-1 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1989 Brügge gnd-content Schizophrenie (DE-588)4052527-2 s Neuroleptikum (DE-588)4041885-6 s Rezidivprophylaxe (DE-588)4177967-8 s Internationaler Vergleich (DE-588)4120509-1 s DE-604 Kissling, Werner Sonstige (DE-588)17218746X oth |
| spellingShingle | Guidelines for neuroleptic relapse prevention in schizophrenia proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium Antipsychotic Agents therapeutic use Congresses Antipsychotic Agents therapeutic use Practice Guideline Antipsychotic drugs Congresses Schizophrenia Chemotherapy Congresses Schizophrenia Relapse Prevention Congresses Schizophrenia drug therapy Congresses Schizophrenia drug therapy Practice Guideline Schizophrenia prevention & control Congresses Schizophrenia prevention & control Practice Guideline Rezidivprophylaxe (DE-588)4177967-8 gnd Schizophrenie (DE-588)4052527-2 gnd Neuroleptikum (DE-588)4041885-6 gnd Internationaler Vergleich (DE-588)4120509-1 gnd |
| subject_GND | (DE-588)4177967-8 (DE-588)4052527-2 (DE-588)4041885-6 (DE-588)4120509-1 (DE-588)1071861417 |
| title | Guidelines for neuroleptic relapse prevention in schizophrenia proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium |
| title_auth | Guidelines for neuroleptic relapse prevention in schizophrenia proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium |
| title_exact_search | Guidelines for neuroleptic relapse prevention in schizophrenia proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium |
| title_full | Guidelines for neuroleptic relapse prevention in schizophrenia proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium ed. by Werner Kissling |
| title_fullStr | Guidelines for neuroleptic relapse prevention in schizophrenia proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium ed. by Werner Kissling |
| title_full_unstemmed | Guidelines for neuroleptic relapse prevention in schizophrenia proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium ed. by Werner Kissling |
| title_short | Guidelines for neuroleptic relapse prevention in schizophrenia |
| title_sort | guidelines for neuroleptic relapse prevention in schizophrenia proceedings of a consensus conference held april 19 20 1989 in bruges belgium |
| title_sub | proceedings of a consensus conference held April 19 - 20, 1989, in Bruges, Belgium |
| topic | Antipsychotic Agents therapeutic use Congresses Antipsychotic Agents therapeutic use Practice Guideline Antipsychotic drugs Congresses Schizophrenia Chemotherapy Congresses Schizophrenia Relapse Prevention Congresses Schizophrenia drug therapy Congresses Schizophrenia drug therapy Practice Guideline Schizophrenia prevention & control Congresses Schizophrenia prevention & control Practice Guideline Rezidivprophylaxe (DE-588)4177967-8 gnd Schizophrenie (DE-588)4052527-2 gnd Neuroleptikum (DE-588)4041885-6 gnd Internationaler Vergleich (DE-588)4120509-1 gnd |
| topic_facet | Antipsychotic Agents therapeutic use Congresses Antipsychotic Agents therapeutic use Practice Guideline Antipsychotic drugs Congresses Schizophrenia Chemotherapy Congresses Schizophrenia Relapse Prevention Congresses Schizophrenia drug therapy Congresses Schizophrenia drug therapy Practice Guideline Schizophrenia prevention & control Congresses Schizophrenia prevention & control Practice Guideline Rezidivprophylaxe Schizophrenie Neuroleptikum Internationaler Vergleich Konferenzschrift 1989 Brügge |
| work_keys_str_mv | AT kisslingwerner guidelinesforneurolepticrelapsepreventioninschizophreniaproceedingsofaconsensusconferenceheldapril19201989inbrugesbelgium |